Tech Company Financing Transactions
CCM Biosciences Funding Round
CCM Biosciences closed a $25 million Series A financing round on 8/30/2023. Backers included .
Transaction Overview
Company Name
Announced On
8/30/2023
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
No investors have been recorded for this company.
Proceeds Purpose
The company is partnered with PMC Group for the Chemistry, Manufacturing, and Controls (CMC) of its drug programs. The CCM-PMC partnership offers a fully integrated ecosystem for the discovery, development, and manufacturing of drug candidates addressing some of the most significant unmet medical needs.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
Undisclosed
Pittsburgh, PA Undisclosed
USA
Pittsburgh, PA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
We offer first-in-class and best-in-class drugs and associated companion diagnostic tests to fulfill unmet market needs using cutting edge technology platforms deeply rooted in science. Leveraging the Chakrabarti Family's top decile quarter century track record in private equity investments, through its VC Management Company, Chakrabarti Capital Management, LLC (CCM) Partnered with global leaders in asset pricing and portfolio optimization to optimally allocate capital across an expansive portfolio of drug programs organized in corporate subsidiaries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raj Chakrabarti
Browse more venture capital transactions:
Prev: 8/30/2023: AI21 Labs venture capital transaction
Next: 8/30/2023: Fianu Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs